Drugs that contain Omega-3-acid Ethyl Esters
1. Lovaza patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5502077 | WOODWARD | Fatty acid composition |
Mar, 2013
(11 years ago) | |
| US5656667 | WOODWARD | Fatty acid composition |
Apr, 2017
(7 years ago) | |
| US7732488 | WOODWARD | Pharmaceutical composition comprising low concentrations of environmental pollutants |
Jan, 2025
(8 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-87) | Sep 16, 2012 |
Market Authorisation Date: 10 November, 2004
Treatment: Use in lipid management
Dosage: CAPSULE;ORAL
How can I launch a generic of LOVAZA before it's drug patent expiration?
More Information on Dosage
LOVAZA family patents
